Friday, February 03, 2017 9:18:20 AM
You were right to be concerned
Have to admit when I'm wrong. I don't understand why they're raising more capital at such a terrible price, but they have. I can only hope that they're anticipating a big uptick in business and felt the need to have more working capital. That said, they should grow the business first and exhaust other non-dilutive sources of capital. The goal should be to maximize valuation not dollars raised. This company seems to have it in reverse at this point.
I emailed my strong concerns this morning to a Board Member. Kind of moot at this point, but I just couldn't let my frustration continue. Fortunately, I sold half my position in the past few days to buy some other stocks. I will look to buy this back (I suppose fortunately at a lower price) as I still believe in the growth outlook. That said, management has zero credibility at this point and must generate revenue growth as reactions to PRs, save for a possible deal with another large insurer or expansion into Europe, won't be met with much enthusiasm.
I'm not sure this is a good thing, but they did add Roth as a financial advisor. Perhaps that means that Roth will launch coverage or maybe there are M&A opportunities that they are considering. Time will tell.
Have to admit when I'm wrong. I don't understand why they're raising more capital at such a terrible price, but they have. I can only hope that they're anticipating a big uptick in business and felt the need to have more working capital. That said, they should grow the business first and exhaust other non-dilutive sources of capital. The goal should be to maximize valuation not dollars raised. This company seems to have it in reverse at this point.
I emailed my strong concerns this morning to a Board Member. Kind of moot at this point, but I just couldn't let my frustration continue. Fortunately, I sold half my position in the past few days to buy some other stocks. I will look to buy this back (I suppose fortunately at a lower price) as I still believe in the growth outlook. That said, management has zero credibility at this point and must generate revenue growth as reactions to PRs, save for a possible deal with another large insurer or expansion into Europe, won't be met with much enthusiasm.
I'm not sure this is a good thing, but they did add Roth as a financial advisor. Perhaps that means that Roth will launch coverage or maybe there are M&A opportunities that they are considering. Time will tell.
Recent IDXG News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:15:35 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:38:48 PM
- Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results • GlobeNewswire Inc. • 03/30/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 09:05:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 11:46:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 02:05:32 PM
- Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure • GlobeNewswire Inc. • 01/20/2026 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2025 09:05:28 PM
- Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners • GlobeNewswire Inc. • 12/03/2025 05:12:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 09:45:44 PM
- Interpace Biosciences Announces Third Quarter 2025 Financial and Business Results • GlobeNewswire Inc. • 11/12/2025 09:01:00 PM
- Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association® (ATA) Annual Meeting • GlobeNewswire Inc. • 09/15/2025 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:28:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2025 08:30:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2025 08:28:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 08:25:28 PM
